João L. Carapinha/LinkedIn
Jul 2, 2026, 20:48
João L. Carapinha: How Does HYMPAVZI Simplify Hemophilia Management for Patients?
João L. Carapinha, Director at Syenza, shared on LinkedIn:
”How does HYMPAVZI simplify hemophilia management for patients?
A new weekly subcutaneous option changes care pathways forever.
FDA approval expands access for adults, adolescents, and children.
This therapy offers flexibility and reduces traditional treatment burdens.
Check out the article for more insights.”
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency